Close this search box.

Patients Benefit from Non-Surgical SRT

October 31, 2016

If you’ve been diagnosed with non-melanoma skin cancer, such as basal cell carcinoma or squamous cell carcinoma, you now have a new, non-surgical option for treatment. Superficial Radio Therapy (SRT) with the SRT-100™ delivers a precise, calibrated dose of SRT that only goes skin deep. This low-dose of Superficial Radio Therapy safely destroys non-melanoma skin cancer cells without damaging healthy surrounding tissue. There is no cutting or stitching, less risk for infection, and no need for reconstructive plastic surgery to repair surgical scars.

With a 95 percent cure rate, SRT does what no other skin cancer treatment can do. It cures skin cancer without ever invading the skin. Performed right in your physician’s office, it delivers optimum results to treat skin cancer without the negative side effects of invasive treatments. This treatment is ideal for patients who have existing medical conditions that may make surgery a serious health risk.

SRT therapy isn’t just for the treatment of non-melanoma skin cancer. If you are living with an ugly, embarrassing or even painful keloid scar, it can help eliminate the keloid and restore your confidence.

Keloids are chronic, non-malignant tumors that often form following surgery, but may also be triggered by other skin traumas, such as acne and chickenpox, ear piercing, burns and other skin injuries. When the skin is wounded — whether through surgery or injury — fibrous tissue called scar tissue forms over the wound. In some cases, excessive scar tissue grows, forming a smooth, hard growth over the incision or injury. This growth is called a keloid and is often much larger than the original wound.

In the past, keloid removal has been difficult, as it requires surgical removal, and in many cases, the keloid grows back at the new incision site. With only surgical keloid removal, the recurrence rate is as high as 90 percent. But with SRT therapy following surgery, recurrence of keloid scars after treatment drops below 10 percent. This is precisely why the SRT-100™ has earned the moniker “The Keloid Cure.” It safely destroys the cells that form keloids, keeping the skin smooth as the incision heals.

If you are dealing with an unsightly keloid scar, or the diagnosis of non-melanoma skin cancer, contact us today to learn more about SRT therapy with the SRT-100™.